Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization
Niklas Zojer(University of Vienna), Johannes Drach(Vienna General Hospital), H. Kaufmann, Heinz Gisslinger(Medical University of Vienna), H. Huber(Munich University of Applied Sciences), Robert Königsberg(Kaiser-Franz-Josef-Spital), Elisabeth Krömer(University of Vienna), S. Schreiber(Wilhelminen Hospital), E. Fritz(Unknown), Jutta Ackermann(University of Vienna), R. Heinz(University of Vienna), Lucia Riedl(Wilhelminen Hospital), Susanne Dallinger(Wilhelminen Hospital), Heinz Ludwig(Wilhelminen Hospital)
Cited by 322
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k